Administered by:

Explore all postings for this grant program:

Applications Due:

May 3, 2005

total funding:

$3,000,000

max award:

$3,000,000

min award:

none

cost sharing, matching:

No

number of awards:

1

type of funding:

Cooperative Agreement, Grant

Description:

The United States Army Medical Research and Materiel Command (USAMRMC), Office of the Congressionally Directed Medical Research Programs (CDMRP) invites applications for funding for the FY05 Neurofibromatosis Consortium Development Operations Center Award (NFCDOCA).

The Neurofibromatosis Research Program (NFRP) seeks to establish a consortium of exceptional investigators that will conceive, develop, and conduct collaborative pilot and Phase I and II clinical evaluations of promising new therapeutic agents or approaches for the management or treatment of neurofibromatosis type 1 (NF1). The Fiscal Year 2005 (FY05) NFRP is offering two separate award mechanisms to support the establishment of the necessary collaborations and development of the necessary resources for the consortium the NF Consortium Development Operations Center Award and the NF Consortium Development Site Award. Proposals for the NF Consortium Development Operations Center Award, which will be used to select the consortium Operations Center, are being requested in this program announcement. The recipient of the FY05 NF Consortium Development Operations Center Award shall collaborate with the recipients of the FY05 NF Consortium Development Site Award to submit a proposal, clinical protocols, and associated clinical documents to the FY06 NF Consortium Award mechanism. However, the FY06 NF Consortium Award will be open to all eligible consortia focused on NF1 clinical research. Funding for the FY05 NF Consortium Development Operations Center Award can be requested for $3 million (M) for 2 years, inclusive of both direct and indirect costs. It is anticipated that one proposal will be funded. FY05 funding will be disbursed in installments as identified in the proposal budget, up to $2M in the first year. Disbursement of the remaining funds is contingent on receipt of FY06 appropriations by the NFRP and submission of a compliant FY06 NF Consortium Award proposal and clinical protocols. There is no guarantee that funds will be available for the FY06 NF Consortium Awards. Please see announcement for complete details of this award mechanism.

Electronic submission is required. Proposals will be accepted only as PDF files submitted through the CDMRP eReceipt system. No paper copy submissions will be accepted. The CDMRP uses a two-tier review process for proposals: scientific peer review, followed by programmatic review. Details of both tiers of review can be found in the Full Text of Program Announcement.